Immediate Physical Therapy for Spondylolysis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new physical therapy program for young athletes with spondylolysis, a condition causing back pain due to a small stress fracture in the spine. The goal is to determine if starting physical therapy immediately, rather than waiting for pain to subside, improves pain, function, and quality of life. It compares two groups: one begins therapy immediately, and the other waits until the pain subsides. Athletes between 10 and 19 years old with a recent diagnosis of spondylolysis who play organized sports at least twice a week may be a good fit.
As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance treatment strategies for young athletes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on physical therapy and does not mention medication changes.
What prior data suggests that the Immediate Functional Progression Program is safe for adolescent athletes with spondylolysis?
Research has shown that the Immediate Functional Progression Program (IFPP) could be a promising treatment for spondylolysis in young athletes. Spondylolysis is a stress fracture in the lower back. Studies suggest that this program might be a well-tolerated method for managing this condition. Previous research described the program as a good option, showing potential for managing active spondylolysis.
Although detailed safety information about this program is limited, its testing in clinical settings suggests a certain level of safety and tolerability. As a pilot study, it aims to assess the program's practicality and safety before larger studies are conducted. In the IFPP, participants begin physical therapy soon after diagnosis, rather than waiting for pain to subside. This early intervention is believed to improve movement and possibly reduce long-term issues.
This approach is still under study, and ongoing research will provide more information about its safety and effectiveness. Prospective participants should discuss with their doctor how this program might fit into their treatment plan.12345Why are researchers excited about this trial?
Researchers are excited about the Immediate Functional Progression Program for spondylolysis because it allows athletes to start physical therapy almost immediately after diagnosis, which is a big shift from the usual "rest until pain resolves" approach. While traditional treatments often require athletes to wait until their pain subsides before beginning physical therapy, this program introduces exercises early, aiming to maintain function and potentially speed up recovery. This proactive approach can help athletes return to their sport faster and with potentially better outcomes, as it focuses on progressing through functional stages rather than just waiting for pain to disappear.
What evidence suggests that the Immediate Functional Progression Program is effective for treating spondylolysis?
Research shows that the Immediate Functional Progression Program (IFPP), which participants in this trial may receive, can help treat spondylolysis in young athletes. Studies have found that starting physical therapy immediately and progressing based on individual performance leads to faster improvements in pain and movement. In one study, 90% of participants showed healing in the affected area within three months. Most participants also reported significant improvements by the end of the program. These findings suggest that IFPP may help young athletes return to sports more quickly and with better results.12456
Are You a Good Fit for This Trial?
This trial is for adolescent athletes aged 10-19 with a recent diagnosis of spondylolysis, which is a type of stress fracture in the lower spine causing back pain. They must be active in sports at least twice weekly and have not taken more than four weeks off due to back pain. Those with previous lumbar surgery, numbness or tingling in the legs, or other serious conditions are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Functional Progression Program (IFPP)
Participants in the IFPP group begin physical therapy immediately upon diagnosis, progressing through three phases based on function and pain criteria.
Control Group Treatment
Participants in the control group begin physical therapy after lumbar pain resolves, following a predetermined timeline for progression.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 1 month, 3 months, 6 months, and 1 year.
What Are the Treatments Tested in This Trial?
Interventions
- Immediate Functional Progression Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nationwide Children's Hospital
Lead Sponsor
Children's Hospital Colorado
Collaborator